Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: Behavioral and biochemical evidence

Behavioural Brain Research

Volumn 205, Issue 2, 2009, Pages 414-420

  Sachdeva, Anand Kamal ^a   Kuhad, Anurag ^a   Tiwari, Vinod ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Brucella abortus; Chronic fatigue syndrome; Epigallocatechin gallate; Lipopolysaccharide; Tumor necrosis factor

Indexed keywords

CATALASE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; LIPID; LIPOPOLYSACCHARIDE; NITRITE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; BRUCELLA ABORTUS; CHEMICAL ANALYSIS; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALITIS; HYPERALGESIA; IMMOBILIZATION; LIPID PEROXIDATION; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SWIMMING;

ANIMALS; ANTIOXIDANTS; BRUCELLA ABORTUS; CATALASE; CATECHIN; DISEASE MODELS, ANIMAL; FATIGUE SYNDROME, CHRONIC; GLUTATHIONE; HYPERALGESIA; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LOCOMOTION; MICE; MICE, INBRED STRAINS; NITRITES; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SWIMMING; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349770539     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.07.020     Document Type: Article

References (57)

1. Ahmed S., Rahman A., Hasnain A., Lalonde M., Goldberg V.M., and Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1ß-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 33 (2002) 1097-1105
2. Ahn H.Y., Xu Y., and Davidge S.T. Epigallocatechin-3-O-gallate inhibits TNF-α-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci 82 (2008) 964-968
3. Anjaneyulu M., and Chopra K. Reversal of lipopolysaccharide-induced thermal and behavioural hyperalgesia by quercetin. Drug Dev Res 58 (2003) 248-252
4. Antonio A.M., and Druse M.J. Antioxidants prevent ethanol-associated apoptosis in fetal rhombencephalic neurons. Brain Res 1204 (2008) 16-23
5. Beutler B., and Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 9 (1988) 57-66
6. Chance W.T., and Fischer J.E. Aphagic and adipsic effects of interleukin-1. Brain Res 568 (1991) 261
7. Chao C.C., DeLaHunt M., Hu S., Close K., and Peterson P.K. Immunologically mediated fatigue: a murine model. Clin Immunol Immunopathol 64 (1992) 161-165
8. Cho H.S., Kim S., Lee S.Y., Park J.A., Kim S.J., and Chun H.S. Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology 29 (2008) 656-662
9. Claiborne A. Catalase activity. CRC handbook of methods for oxygen radical research;1985:283-284.
10. Crestani F., Seguy F., and Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res 542 (1991) 330-335
11. Duff G.W., and Durum S.K. The pyrogenic and mitogenic actions of interleukin-1 are related. Nature 304 (1983) 449-451
12. Fang H., Xie Q., Boneva R., Fostel J., Perkins R., and Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics 7 (2006) 429-440
13. Fantino M., and Wieteska L. Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat. Physiol Behav 53 (1993) 477-483
14. Gaab J., Engert V., Heitz V., Schad T., Schürmeyer T.H., and Ehlert U. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. J Psychosom Res 56 (2004) 419-424
15. Gaab J., Rohleder N., Heitz V., Engert V., Schad T., Schürmeyer T.H., et al. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinolgy 30 (2005) 188-198
16. Gupta A., Vij G., Sharma S., Tirkey N., Rishi P., and Chopra K. Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology 214 (2009) 33-39
17. Halliwell B., Aeschbach R., Loliger J., and Aruoma O.I. The characterization of antioxidants. Food Chem Toxicol 33 (1995) 601-617
18. Hayashi K., Takai S., Matsushima-Nishiwaki R., Hanai Y., Kato K., Tokuda H., et al. (-)-Epigallocatechin gallate reduces transforming growth factor ß-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts. Life Sci 82 (2008) 1012-1017
19. He P., Noda Y., and Sugiyama K. Green tea suppresses lipopolysaccharide-induced liver injury in d-galactosamine-sensitized rats. J Nutr 131 (2001) 1560-1567
20. Hsu S., and Dickinson D. A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus. J Biochem Mol Biol 39 (2006) 229
21. Hussain T., Gupta S., Adhami V.M., and Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 113 (2005) 660-669
22. Jain N.K., Patil C.S., Kulkarni S.K., and Singh A. Rofecoxib reversal of lipopolysaccharide-mediated central and peripheral hyperalgesia. Brain Pharmacol 1 (2001) 73-81
23. Jollow D.J., Mitchell J.R., Zampaglione N., and Gillette J.R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11 (1974) 151-169
24. Kaur S., Anurag A., Tirkey N., and Chopra K. Reversal of LPS-induced central and peripheral hyperalgesia by green tea extract. Phytother Res 19 (2005) 39-43
25. Kaushik N., Fear D., Richards S.C.M., McDermott C.R., Nuwaysir E.F., Kellam P., et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol (2005) 826-832
26. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186 (1978) 189
27. Krueger J.M., Walter J., Dinarello C.A., Wolff S.M., and Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 246 (1984) 994-999
28. Lacosta S., Merali Z., and Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res 818 (1999) 291-303
29. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R., et al. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol 279 (2000) 93-98
30. Lerner A.M., Beqaj S.H., Deeter R.G., and Fitzgerald J.T. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo 18 (2004) 101-106
31. Lin Y.L., and Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 52 (1997) 465-472
32. Lloyd A.R., Wakefield D., Boughton C.R., and Dwyer J.M. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust 151 (1989) 122-124
33. MacDonald K.L., Osterholm M.T., LeDell K.H., White K.E., Schenck C.H., Chao C.C., et al. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med 100 (1996) 548-554
34. Maes M., Mihaylova I., and Bosmans E. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuro Endocrinol Lett 28 (2007) 456-462
35. Maes M., Mihaylova I., and Leunis J.C. Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett 27 (2006) 615-622
36. Mandel S., Weinreb O., Amit T., and Youdim M.B.H. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J Neurochem 88 (2004) 1555-1569
37. Manuel K.B., Moorkens G., Vertommen J., and De Leeuw I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci 68 (2001) 2037-2049
38. McCarthy D.O., Kluger M.J., and Vander A.J. Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats. Physiol Behav 36 (1986) 745-749
39. Morganti-Kossmann M.C., Rancan M., Stahel P.F., and Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 8 (2002) 101-105
40. Murphy E.A., Sathiyaseelan J., Parent M.A., and Zou B. Interferon-c is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103 (2001) 511-518
41. Nijs J., and De Meirleir K. Oxidative stress might reduce essential fatty acids in erythrocyte membranes of chronic fatigue syndrome patients. Nutr Neurosci 7 (2004) 251-253
42. Patarca R., Lugtendorf S., Antoni M., Klimas N.G., and Fletcher M.A. Dysregulated expression of tumor necrosis factor in the chronic fatigue immune dysfunction syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 18 (1994) S147-S153
43. Peterson P.K., Sirr S.A., Grammith F.C., Schenck C.H., Pheley A.M., Hu S., et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin Vacc Immunol 1 (1994) 222-226
44. Raghavendra V., and Kulkarni S.K. Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors. Brain Res 834 (1999) 178-181
45. Sakaguchi S., and Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol 47 (2006) 167-177
46. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
47. Singh R., Ahmed S., Islam N., Goldberg V.M., and Haqqi T.M. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 46 (2002) 2079-2086
48. Sueoka N., Suganuma M., Sueoka E., Okabe S., Matsuyama S., Imai K., et al. A new function of green tea: prevention of lifestyle-related diseases. Ann NY Acad Sci 928 (2001) 274-280
49. Sugino K., Dohi K., Yamada K., and Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 101 (1987) 746-750
50. Svetic A., Jian Y.C., Lu P., Finkeiman F.D., Gause W.C., and Paul W.E. Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. Int Immunol 5 (1993) 877-883
51. Tomoda A., Joudoi T., Rabab E.M., Matsumoto T., Park T.H., and Miike T. Cytokine production and modulation: comparison of patients with chronic fatigue syndrome and normal controls. Psychiatry Res 134 (2005) 101-104
52. Tracey K.J., Vlassara M., and Cerami A. Cachectin/tumour necrosis factor. Lancet (1989) 1122-1126 (British edition)
53. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99 (1966) 667-676
54. Wilt S.G., Milward E., Zhou J.M., Nagasato K., Patton H., Rusten R., et al. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 37 (1995) 381-394
55. Yang F., de Villiers W.J.S., McClain C.J., and Varilek G.W. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 128 (1998) 2334-2340
56. Yumei F., Zhou Y., Zheng S., and Chen A. The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab Invest 86 (2006) 697-709
57. Zhang B., Rusciano D., and Osborne N.N. Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Res 1198 (2008) 141-152